Peraso (PRSO): CTO Granted 25,000 Options, $0.8399 Strike, Aug 7, 2025
Peraso Inc. (PRSO) Chief Technology Officer Alex Tomkins was granted a stock option to purchase 25,000 shares on August 7, 2025 with an exercise price of $0.8399.
Rhea-AI Filing Summary
Peraso Inc. (PRSO) Chief Technology Officer Alex Tomkins was granted a stock option to purchase 25,000 shares on August 7, 2025 with an exercise price of $0.8399. The option is reported as direct beneficial ownership of 25,000 derivative securities and the filing shows the option price reported as $0.00 in the form's table.
The option vests as to 1/36th of the shares on each monthly anniversary following August 7, 2025. The Form 4 was signed by James Sullivan by power of attorney on August 11, 2025. The filing does not disclose total shares outstanding or the percentage this grant represents, so materiality relative to the company's equity cannot be determined from this Form 4 alone.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine executive equity grant; 25,000 options to CTO, materiality unclear without outstanding share count.
The Form 4 documents a standard option award to Alex Tomkins, CTO, for 25,000 options with a $0.8399 exercise price granted on 08/07/2025. Vesting is monthly at 1/36th per month beginning August 7, 2025. The filing reports the options as directly beneficially owned. Without the issuer's total share count or prior holdings detail, the quantitative impact on dilution or insider ownership percentages cannot be assessed from this filing alone.
TL;DR: Standard compensation grant with monthly vesting; governance impact limited to disclosure and alignment considerations.
This Form 4 shows an equity compensation action for a named officer (CTO). The vesting schedule—1/36th monthly—ties compensation to continued service. The form contains the grant date, strike, and quantity but omits context such as percent of outstanding shares or board authorization details; therefore the filing alone provides limited insight into governance implications beyond confirming the award and vesting terms.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 25,000 | $0.00 | $0.00 |
Footnotes (2)
- F1. The option will vest as to 1/36th of the shares subject to the option on each monthly anniversary following August 7, 2025.
- F2. In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Peraso (PRSO) report in this Form 4?
What are the vesting terms for the option reported on Peraso's Form 4?
How is the reported ownership described in the filing for PRSO?
Who signed the Form 4 for Peraso and when was it filed?
What is the exercise price and any price noted on the derivative security line?
Does the Form 4 disclose how material the grant is relative to company equity?
AI-generated analysis. How Rhea-AI works. Not financial advice.